Kirpekar Sahil — SEC Form 4 filings

SEC reporting owner CIK 1951712. 4 Form 4 filings on record with FilingPulse; latest filed 2025-03-24.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-03-15 to 2025-03-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ATAI Life Sciences N.V. (ATAI)Chief Business Officer42 legs · 84,364 sh · $131,7925

Form 4 filings — Kirpekar Sahil

FiledFormIssuerReported transactionsSource
2025-03-244ATAI Life Sciences N.V. (ATAI)Sale (S): 48,563 @ $1.35EDGAR
2025-03-194ATAI Life Sciences N.V. (ATAI)Option exercise (M): 100,000 · Option exercise (M): 100,000 (derivative)EDGAR
2024-04-044ATAI Life Sciences N.V. (ATAI)Sale (S): 35,801 @ $1.85EDGAR
2024-03-154ATAI Life Sciences N.V. (ATAI)Option exercise (M): 100,000 · Grant/award (A): 550,000 (derivative) @ $0 · Option exercise (M): 100,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1951712 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →